Target intelligence / Profile preview

Transmembrane protein 183A pseudogene 6 (TMEM183AP6)

Target
TMEM183AP6
Molecular classification
Other (Pseudogene)
01

Overview

TMEM183AP6 is categorized as a pseudogene, meaning it is a DNA sequence similar to a functional gene (here, TMEM183A), but typically is noncoding and does not produce a functional transmembrane protein. Most pseudogenes do not encode proteins; however, some may be transcribed into RNA and play roles in gene regulation, such as acting as microRNA decoys or influencing the expression of their parental genes or related genes by competing for regulatory elements[1]. There is no evidence that TMEM183AP6 encodes a functional protein or acts as a receptor, enzyme, transporter, or similar therapeutic target. No drugs, biomarkers, or established disease associations are directly linked to this specific pseudogene. The "is_incorrect" flag is set to true because, while TMEM183AP6 exists as a sequence, it is not a validated drug target, receptor, or functionally characterized molecule. This entry represents a noncoding pseudogene, not a protein or conventional therapeutic target. Although some pseudogenes can act as disease regulators through noncoding RNA mechanisms, no evidence of such function exists for TMEM183AP6 specifically in current scientific literature[1].

Other names
TMEM183AP6transmembrane protein 183A pseudogene
02

Mechanism of action

none (no validated drug interactions)

03

Biological functions

Other (potential regulatory function as a noncoding RNA, but not as a protein or therapeutic target)
04

Disease associations

Other (pseudogenes may act as regulators in cancer and other diseases, but there is no specific evidence for TMEM183AP6 in the literature)

Beyond the preview

Go deeper on Transmembrane protein 183A pseudogene 6 (TMEM183AP6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 183A pseudogene 6 (TMEM183AP6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call